JPM
69
2
LEG
64
5
TRV
55
6
BXP
46
5
RCL
73
8
OMC
69
4
PNC
80
4
WAT
50
-3
NDAQ
74
4
AAP
24
-3
MAR
65
14
AES
57
2
BAX
48
4
RL
79
3
VRSK
23
2
ITW
42
2
AA
72
3
AME
69
6
EQT
53
-4
MNST
47
-3
JPM
69
2
LEG
64
5
TRV
55
6
BXP
46
5
RCL
73
8
OMC
69
4
PNC
80
4
WAT
50
-3
NDAQ
74
4
AAP
24
-3
MAR
65
14
AES
57
2
BAX
48
4
RL
79
3
VRSK
23
2
ITW
42
2
AA
72
3
AME
69
6
EQT
53
-4
MNST
47
-3
Financhill
Back

Sylvania Platinum Ltd. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
36

SAPLF
Sylvania Platinum Ltd.

Last Price:
$1.24
Seasonality Move:
3.85%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$53.94
Seasonality Move:
11.58%
Sell
36
Sylvania Platinum Ltd. (SAPLF) is a Sell

Is Sylvania Platinum Ltd. a Buy, Sell or Hold?

  • The current Sylvania Platinum Ltd. [SAPLF] share price is $1.14. The Score for SAPLF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SAPLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SAPLF Stock Price Chart

What is Sylvania Platinum Ltd.'s stock price today?

  • The Sylvania Platinum Ltd. share price today is $1.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAPLF is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

SAPLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 46.39 Sell
Chaikin Money Flow: -66027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.09 - 1.21) Sell
Bollinger Bands (100): (1.02 - 1.22) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

SAPLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.21 Sell
20-day SMA: 1.16 Sell
50-day SMA: 1.17 Sell
200-day SMA: 0.94 Buy
8-day EMA: 1.2 Sell
20-day EMA: 1.18 Sell
50-day EMA: 1.16 Sell
200-day EMA: 0.99 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

Sylvania Platinum Ltd. Earnings Growth & SAPLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Sylvania Platinum Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):